If you’re exрloring treаtments for your аutoimmune сonԁition, terms like T-reg lymрhoсytes саn mаke the рroсess feel overwhelming. However, by unԁerstаnԁing new terminology, you саn better unԁerstаnԁ how these new treаtments work аnԁ whether they’re the right fit for you.
Keep reading while we discuss what T-reg cells are, their therapeutic potential and emerging approaches of T-reg therapy.
What are T-reg Lymphocytes?
T-reg lymphocytes are a subpopulation of T cells that control immune response. They tell your body how to respond to foreign substances, such as bacteria, and can help prevent autoimmunity by stopping the immune system from attacking your body’s own cells.
Therapeutic Potential of T-reg Lymphocytes
Due to the ability of T-reg lymphocytes to maintain immune homeostasis and self-tolerance, they hold great therapeutic potential in the treatment of autoimmune disorders like multiple sclerosis (MS).
Current Applications of T-reg Lymphocytes
T-reg lymphocytes are currently together with stem cell treatment. Swiss Medica, a stem cell treatment center in Serbia, uses regulatory T-cells during the treatment of autoimmune diseases like multiple sclerosis. MS patients who receive stem cell therapy together with t-reg lymphocytes can see benefits such as:
- Reduction in fatigue
- improved mobility
- Overall improvement in quality of life
Photo by Rollz International on Unsplash
T-reg lymphocytes aren’t a cure for MS, but their stabilizing effect on the immune system can reduce symptoms and prevent disease regression. T-reg cells can also play a role in treating other disorders that are linked with immune system dysfunction, such as autism and Parkinson’s disease.
Emerging Strategies in T-reg Therapy
Chimeric Antigen Receptor (CAR)-Treg therapy
CAR-Treg therарy is а new form of t-reg therарy аimeԁ аt imрroving the sрeсifiсity аnԁ рotenсy of t-regulаtory сells in the treаtment of аutoimmune ԁiseаse.
CAR T-reg therарy uses t-reg сells thаt hаve been genetiсаlly engineereԁ to tаrget sрeсifiс аntigens, whiсh meаns they саn tаrget sрeсifiс аntigens without саusing wiԁesрreаԁ immunosuррression. Through genetiс engineering, lаb teсhniсiаns саn аlso moԁify t-reg сells to oрtimize their survivаl аnԁ immunosuррressive effeсts.
CAR t-reg therapy has shown significant potential in treating autoimmune diseases like MS. In a mouse model studying the effects of CAR t-reg therapy on MS, the adoptive transfer of t-regs was shown to be effective at reducing symptoms of the disease.
T-cell receptor (TCR)-Treg therapy
T cells bind to antigens through receptors. When the T cell binds to an antigen, it can destroy the antigen’s cells. TCR t-reg therapy uses T cells with modified receptors that allow them to better recognize foreign antigens.
While both TCR and CAR therapy are focused on modifying cells to recognize certain pathogens, TCR therapy may be able to recognize a wider range of antigens, making it a more effective treatment for some diseases. According to research, TCR therapy could also have therapeutic potential in treating MS.
Future Perspectives of T-reg Lymphocytes in Therapy
There has been extensive research into the therapeutic potential of t-reg lymphocytes. For example, there have been many successful animal studies proving the safety and efficacy of this treatment. Now, researchers will continue to conduct clinical trials to further establish the safety and efficacy of the treatment.
Photo by Louis Reed on Unsplash
Challenges and Risks
There are some challenges in using t-reg cells to treat autoimmune diseases. For example, treating autoimmune disorders requires a high quantity of t-reg cells and isolating t-reg cells in high quantities can be difficult. Increasing the durability and stability of t-reg cells remains another challenge for t-reg therapy.
Modifying t-reg cells for these therapies can also be complex and expensive, and there is a risk of contamination with non-treg cells. Future t-reg therapy research will likely focus on developing an efficient manufacturing process, assessing treg durability and stability, and finding new techniques for administering the therapy.
In conclusion
T-reg lymphocytes play a key in the immune system, as they control immune response to pathogens and prevent autoimmunity. This makes t-reg therapy a prime candidate for treating autoimmune diseases like MS. When used together with stem cell therapy. Patients can see a reduction in symptoms and improved quality of life.
CAR therapy and TCR therapy are the most common t-reg lymphocyte treatments. They use genetically engineered T-cells that can identify specific antigens and suppress immune responses. Mouse models have shown the therapeutic potential of these therapies, but clinical trials are needed to further prove safety and efficacy.
